MedPath

Carbidopa Tablets, 25 mg

Carbidopa Tablets, 25 mg

Approved
Approval ID

97e7696c-5220-e5c3-9429-7fad5eda33fe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 14, 2023

Manufacturers
FDA

Alvogen Inc.

DUNS: 008057330

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Carbidopa Tablets, 25 mg

PRODUCT DETAILS

NDC Product Code47781-332
Application NumberANDA204291
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateApril 17, 2012
Generic NameCarbidopa Tablets, 25 mg

INGREDIENTS (5)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CARBIDOPAActive
Quantity: 25 mg in 1 1
Code: MNX7R8C5VO
Classification: ACTIM
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carbidopa Tablets, 25 mg - FDA Drug Approval Details